Funder
National Natural Science Foundation of China
High-Tech Research Development Project
Publisher
Springer Science and Business Media LLC
Reference45 articles.
1. Grillo-Lopez, A. J. et al. Overview of the clinical development of rituximab: first monoclonal antibody approved for the treatment of lymphoma. Semin Oncol 26, 66–73 (1999).
2. Lim, S. H. et al. Anti-CD20 monoclonal antibodies: historical and future perspectives. Haematologica 95, 135–143 (2010).
3. Glennie, M. J., French, R. R., Cragg, M. S. & Taylor, R. P. Mechanisms of killing by anti-CD20 monoclonal antibodies. Mol Immunol 44, 3823–3837 (2007).
4. Rodrigues, M. E., Costa, A. R., Henriques, M., Azeredo, J. & Oliveira, R. Technological progresses in monoclonal antibody production systems. Biotechnol Prog 26, 332–351 (2010).
5. Houdebine, L. M. Antibody manufacture in transgenic animals and comparisons with other systems. Curr Opin Biotechnol 13, 625–629 (2002).
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献